• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
YUAN Guiyan,LIU Huanjun,LI Rong,GUO Ruichen.Correlation of liver function abnormality and plasma concentration of high dose methotrexate in patients with osteosarcoma[J].Journal Of Pharmaceutical Research,2021,40(5):339-341,349[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2607times   Download 2427次 QR Code for this article
Scan with your phone!
骨肉瘤患者行大剂量甲氨蝶呤化疗后肝功能异常及与血药浓度的相关性分析
袁桂艳,刘焕君,李荣,郭瑞臣
Font:Larger+|Default|Smaller-
(山东大学齐鲁医院药学部,山东 济南 250012)
摘要:
目的 分析骨肉瘤患者大剂量甲氨蝶呤化疗肝功能异常及其血浓度分布特点,探讨肝肝功能异常与甲氨蝶呤血浓度的相关性。方法 回顾性收集30例骨肉瘤患者大剂量甲氨蝶呤化疗肝功能指标及化疗后0、24、48和72 h的甲氨蝶呤血浓度,统计分析化疗后肝功能异常情况及其与甲氨蝶呤不同时间点血药浓度的相关性。结果 大剂量甲氨蝶呤化疗后肝功能异常总发生率为84.62%,II级及II级以上占44.23%;化疗后肝功能指标ALT、AST与甲氨蝶呤化疗后0 h和24 h的血药浓度呈正相关,而与48 h和72 h血药浓度相关性不大。结论 大剂量甲氨蝶呤化疗引起的肝功能异常发生率高,0 h和24 h血药浓度与大剂量甲氨蝶呤化疗引起的肝功能异常具有显著相关性。
关键词:  骨肉瘤  大剂量甲氨蝶呤  肝功能异常  血药浓度
DOI:10.13506/j.cnki.jpr.2021.05.012
基金项目:山东大学齐鲁医院科研基金青年项目(No.2017QLQN41)
Correlation of liver function abnormality and plasma concentration of high dose methotrexate in patients with osteosarcoma
YUAN Guiyan,LIU Huanjun,LI Rong,GUO Ruichen
(Department of Pharmacy, Qilu Hospital of Shandong University, Jinan 250012,China)
Abstract:
Objective To analyze the characteristics of abnormal liver function and the distribution of plasma concentration of high dose methotrexate in patients with osteosarcoma, and to explore the correlation between abnormal liver function and plasma concentration of methotrexate.Methods The liver function and plasma concentration of methotrexate at 0, 24, 48 and 72 h of 30 patients with osteosarcoma treated with high dose methotrexate were collected retrospectively. The correlation of liver function abnormality and plasma concentration of methotrexate at different time points were statistically analyzed.Results The total incidence of liver function abnormality after high dose methotrexate chemotherapy was 84.62%, including 44.23% of grade II and above. ALT and AST were positively correlated with plasma concentration of methotrexate at 0 h and 24 h after chemotherapy, but not correlated with plasma concentration of methotrexate at 48 h and 72 h.Conclusion The incidence of liver function abnormality induced after high dose methotrexate chemotherapy is very high. The plasma concentration of methotrexate at 0 h and 24 h was significantly correlated to liver function abnormality induced by high dose methotrexate chemotherapy.
Key words:  Osteosarcoma  High dose methotrexate  Liver function abnormality  Plasma concentration
Today's Visits:483    Total Visits:2383194
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.